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Salmonella enterica serovars Typhi and Paratyphi A cause systemic infections in humans which are referred
to as enteric fever. Multidrug-resistant (MDR) serovar Typhi isolates emerged in the 1980s, and in recent years
MDR serovar Paratyphi A infections have become established as a significant problem across Asia. MDR in
serovar Typhi is almost invariably associated with IncHI1 plasmids, but the genetic basis of MDR in serovar
Paratyphi A has remained predominantly undefined. The DNA sequence of an IncHI1 plasmid, pAKU_1,
encoding MDR in a serovar Paratyphi A strain has been determined. Significantly, this plasmid shares a
common IncHI1-associated DNA backbone with the serovar Typhi plasmid pHCM1 and an S. enterica serovar
Typhimurium plasmid pR27. Plasmids pAKU_1 and pHCM1 share 14 antibiotic resistance genes encoded
within similar mobile elements, which appear to form a 24-kb composite transposon that has transferred as a
single unit into different positions into their IncHI1 backbones. Thus, these plasmids have acquired similar
antibiotic resistance genes independently via the horizontal transfer of mobile DNA elements. Furthermore,
two IncHI1 plasmids from a Vietnamese isolate of serovar Typhi were found to contain features of the backbone
sequence of pAKU_1 rather than pHCM1, with the composite transposon inserted in the same location as in
the pAKU_1 sequence. Our data show that these serovar Typhi and Paratyphi A IncHI1 plasmids share highly
conserved core DNA and have acquired similar mobile elements encoding antibiotic resistance genes in past
decades.
Salmonella enterica serovars Typhi and Paratyphi A are hu-
man-adapted bacterial pathogens that cause related systemic
diseases, collectively called enteric fever or typhoid. While
endemic enteric fever has been eliminated from most devel-
oped nations by improved sanitation (6), enteric fever is still a
significant health threat in Southeast Asia, the Indian subcon-
tinent, Africa, and, to a lesser extent, South America (16, 34,
38, 40). Historically, enteric fever has been a target of control
programs and vaccines, but antibiotic treatment remains a cen-
tral pillar of control (13). The appearance of both plasmid-
mediated antibiotic resistance against conventional antityphoid
drugs and chromosomal resistance to the fluoroquinolones has
reduced therapeutic options to the more recently developed beta-
lactams or macrolides. Resistance to both of these can be ac-
quired through the acquisition of plasmids. This alarming situa-
tion has led to concern in countries where disease is endemic and
to enhanced surveillance in countries into which enteric fever
is imported.
Antibiotic resistance in serovar Typhi emerged in the 1970s,
initially as chloramphenicol resistance but later as multidrug
resistance (MDR) (25). MDR serovar Typhi strains have per-
sisted in many areas and are now a huge clinical problem (22,
41). Serovar Paratyphi A is generally regarded as a less com-
mon cause of enteric fever than serovar Typhi, but this serovar
causes approximately 25% of enteric fever cases in some re-
gions (27). Unlike serovar Typhi, serovar Paratyphi A isolates
have predominantly been susceptible to antibiotics (26, 35).
However, in recent years there have been increasing incidents
of MDR serovar Paratyphi A, particularly in Asia (2, 4, 17, 24,
32, 37, 44). A recent study in Nepal found MDR was more
common among serovar Paratyphi A than serovar Typhi iso-
lates (31). The situation is perhaps most extreme in China,
where paratyphoid fever is now more common than typhoid
fever in some regions and is largely drug resistant (27, 45).
Additionally, many serovar Paratyphi A isolates are resistant to
quinolones, and so, as with serovar Typhi-associated typhoid,
the infection responds poorly to treatment with the fluoro-
quinolones (42).
IncHI1 plasmids have been shown to encode the MDR phe-
notype in the vast majority of serovar Typhi isolates analyzed.
The few studies which have reported MDR in serovar Para-
typhi A have pointed to a key role for plasmids in mediating
resistance although few molecular studies have been under-
taken (11). A large transferable plasmid of 140 MDa (230
kb) was found in 73% of MDR strains in Bangladesh in 1992
to 1993 (14). A similarly sized plasmid was reported in recent
Chinese serovar Paratyphi A isolates (45). However, in Cal-
cutta, India, a smaller plasmid (55 kb) was responsible for
conferring MDR in serovar Paratyphi A isolates (23).
Here, we report the complete sequence of a 212-kb IncHI1
resistance plasmid from a serovar Paratyphi A strain isolated
from a Pakistani patient in Karachi in 2002, and we provide
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conclusive proof that similar IncHI1 plasmids can encode the
MDR phenotype in both serovar Typhi and serovar Paratyphi
A. Our data show that these IncHI1 plasmids share highly
conserved core DNA and have acquired similar mobile ele-
ments encoding antibiotic resistance genes on several occa-
sions in past decades.
MATERIALS AND METHODS
The 212,711-bp plasmid pAKU_1 was sequenced as part of a whole-genome
sequencing project for the parent strain (S. enterica Paratyphi A AKU_12601),
the results of which will be reported elsewhere. The whole-genome shotgun
consisted of 83,857 paired-end reads from libraries of 2 to 2.8 kb in pUC19, 5 to
6 kb in pMAQ1, and 6 to 9 kb in pMAQ1, giving 9.8-fold coverage. A scaffold was
produced using 1,180 paired-end reads from a 20- to 30-kb library in pBACe3.6.
The whole genome sequence was finished to standard criteria (28), using 9,879
directed sequencing reads. From the total of 94,916 shotgun and directed reads,
5,032 reads were used to assemble the plasmid sequence, giving around 12.9-fold
final coverage of the plasmid. The sequence was annotated, and the annotation
was manually curated using Artemis software (33) as previously described (28).
Pairwise sequence comparisons were generated with BLASTN and visualized
using ACT (3). Nucleotide differences between backbone sequences were deter-
mined using the nucmer and show-snps programs in the MUMmer package (18).
Nucleotide sequence accession number. The sequence of the pAKU annotated
plasmid has been submitted to the EMBL database under accession number
AM412236.
RESULTS
Plasmid pAKU_1 has a conserved backbone highly related
to other IncHI1 plasmids. The DNA sequence of plasmid
pAKU_1 encoding MDR harbored in an S. enterica serovar
Paratyphi A isolate from Pakistan was determined. Compari-
son with sequence databases revealed high DNA sequence
similarity between pAKU_1 and two IncHI1 plasmids: pR27
from S. enterica serovar Typhimurium isolated in the United
Kingdom in 1961 (12, 36) (EMBL accession no. AF250878)
and pHCM1 from serovar Typhi CT18 isolated in Vietnam in
1993 (29) (EMBL accession no. AL513383). Detailed compar-
ative analysis of the three plasmid sequences revealed a 164.4-kb
shared IncHI1-associated backbone, which showed 99.7% nu-
cleotide identity across the three plasmids. This shared back-
bone constitutes 83% of pAKU_1 sequence and includes the
IncHI1 incompatibility locus and three potential replicon ele-
FIG. 1. (a) Representative alignment of the 164-kb IncHI1 backbone sequences of pAKU_1, pR27, and pHCM1, with the sites of major
insertions, deletions, and inversions indicated. Note that the plasmids are actually circular and are shown as linear here merely for ease of
comparison. Red boxes show the sites of IncHI1 replicons; the green box represents the incompatibility region. Blue boxes represent resistance
gene insertions, scaled to indicate relative size compared to backbone, and are labeled as in Fig. 2 (a, Tn9; b, Tn21; c, class 1 integron; d, bla/sul/str;
e, Tn10; e*, truncated Tn10). Other insertions are shown in white boxes. Inversions are shown as graded black and gray boxes; the gradient
indicates direction. Black bars indicate PCR target amplicons, labeled (A to J) as in Table 2 and Fig. 3. (b) Tree showing the relationship between
the 164-kb IncHI1 backbone sequences of the three plasmids, based on single-nucleotide changes. Branch lengths are proportional to the number
of changes, indicated next to branches. The positions of four major rearrangements (marked by a caret in a) are indicated; the position of the root
is imprecise due to a lack of suitable plasmid sequences for use as outgroups.
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ments (RepHI1A, RepHI1B, and RepFIA) characteristic of
IncHI1 plasmids (9), the locations of which are indicated in
Fig. 1a. The rest of the shared backbone harbors genes in-
volved in the core plasmid functions of replication, mainte-
nance, and conjugative transfer, as well as many hypothetical
genes with no database matches to sequences outside pR27,
pHCM1, and the Serratia marcescens IncHI2 plasmid pR478
(10) (EMBL accession no. BX66401; August 2006).
The shared IncHI1 backbone sequences of pAKU_1, pR27,
and pHCM1 were aligned, and nucleotide differences were
determined using MUMmer (see Materials and Methods).
This analysis found that pAKU_1 shared 99.71% nucleotide
identity with pHCM1 and 99.89% with pR27. Figure 1b shows
an unrooted phylogenetic tree based on the number of single-
nucleotide changes found among the three IncHI1 backbones.
As the tree shows, the plasmid backbone of pAKU_1 is clearly
closer to that of pR27 than pHCM1. This is supported by the
presence of shared variations in the backbones of pAKU_1 and
pR27 relative to pHCM1. These are marked with a caret in Fig.
1a and include a small inversion near the 5 end, two deletions
downstream of this inversion, and a gene (annotated as R0107
in pR27 and SPA0320 in pAKU_1) inserted at the 3 end of the
shared backbone. A large region is inverted on pAKU_1 rel-
ative to pR27 and pHCM1; however, this occurred on
pAKU_1 or a similar precursor plasmid rather than a common
ancestor of pR27 and pHCM1 (see Fig. 3).
Prior to further analysis of the sequenced plasmids, we de-
termined whether IncHI1 plasmids are more generally respon-
sible for MDR in serovar Paratyphi A. A large number of
MDR serovar Paratyphi A isolates from Pakistan obtained
from 2002 to 2004 were analyzed for MDR and IncHI1 plas-
mid content. Of 81 serovar Paratyphi A isolates analyzed, 68
were MDR, and 67 of these were determined by PCR to
contain the IncHI1 replicon (primers are given in Table 1). In
contrast, none of the susceptible serovar Paratyphi A isolates
tested positive for IncHI1. To confirm the presence of plasmids
in MDR serovar Paratyphi A, plasmid preparations were an-
alyzed for 33 MDR and 5 susceptible serovar Paratyphi A
strains. All 33 MDR serovar Paratyphi A isolates harbored a
single plasmid of approximately 220 kb, similar in size to
pAKU_1 (212 kb); 4 of the susceptible serovar Paratyphi A
isolates were plasmid free, and 1 contained two small plasmids.
Comparison of MDR genes in serovar Paratyphi A and
serovar Typhi plasmids. The pAKU_1 plasmid sequence con-
tained multiple antibiotic resistance gene elements inserted
into the IncHI1 backbone. Interestingly, these insertions are
highly clustered relative to the conserved IncHI1 backbone
and are also related to antibiotic resistance genes found on
pHCM1 but not pR27, as shown in Fig. 1a. These resistance
genes can be attributed to the independent insertion of previ-
ously described transposable elements (Fig. 2) into different
positions in the plasmids’ IncHI1 backbones. Tn10, containing
the tetracycline resistance (tet) gene (Fig. 2e) (19), is present
on pAKU_1, pR27, and pHCM1, although part of the trans-
poson is missing from pHCM1. The site of the Tn10 insertion
into the backbone is different in each plasmid, indicating that
the transposon was independently acquired in each rather than
by a common ancestor. No further resistance insertions are
present on pR27. Tn9, with identical copies of the chlor-
amphenicol resistance gene cat (1) (Fig. 2a) is present on
TABLE 1. PCR primers used in this studya
PCR target
ampliconb
Primer Length in plasmid (bp)
Target featured
Directionc Sequence pAKU_1 pHCM1
IncHI1 F CGAAATCGGTCCAACCCATTG 110 NAe RepHI1A
R CGACAACTCATCAGAAGCGTCAAC
A F GAAAGGAATCATCCACCTTCA 419 990 Deletion on pAKU_1
R AACTGTCGCTACGCCTGACT
B F ATCCAGCGTGCAAAGATTTC 407 2,589 Deletion on pAKU_1
R TGGGGGAGAACACCACTTTA
C F AAAGATGCAATGGGAGGAGA 289 4,399 Insertion on pHCM1
R GCGCAGCTGCTTCAATTA
D F TAGGGTTTGTGCGGCTTC 3,138 None Insertion on pAKU_1
R CCTTCTTGTCGCCTTTGC
E F TCAAGGCAGATGGCATTCCC 156 None sul1
R CGACGAGTTTGGCAGATGATTTC
F F GTGTCGAGGAAAGGAATTTCAAGCTC 191 None dfrA7
R TCACCTTCAACCTCAACGTGAACAG
G F GATGGAGAAGAGGAGCAACG 989 989 strB, tniA
R TTCGTTCCTGGTCGATTTTC
H F GTGCTGTGGAACACGGTCTA 271 1,598 tnpA, Tn21 IR
R TCATCAACGCTTCCTGAATG
I F ACGAAAGGGGAATGTTTCCT 163 1,490 merR, Tn21 IR
R CGAGTGGGAATCCATGGTAG
J F CAAAATGTTCTTTACGATGCC 2,219 None cat, backbone (trhN)
R CCAGACAGGAAAACGCTCA
a Primers used to detect the IncHI1 replicon in seovar Paratyphi A plasmids from Pakistan and to detect features of the IncHI1 backbone and resistance gene
insertions in pAKU_1, pHCM1, and two additional serovar Typhi plasmids from Vietnam (A to J).
b The locations of amplicons A to J in pAKU_1 are shown in Fig. 1; the locations of E to J are shown in Fig. 3.
c F, forward; R, reverse.
d IR, inverted repeat; parentheses indicate backbone gene targeted by PCR.
e NA, not applicable.
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pAKU_1 and pHCM1. The transposition of Tn9 is accompa-
nied by target site duplications which show that the Tn9 inser-
tion site was different in pAKU_1 and pHCM1. Tn21, harbor-
ing a class I integron and mercury resistance (mer) operon
(20), can also be identified on both pAKU_1 and pHCM1,
although in each case the primary transposable element has
been disrupted by IS26 insertions and subsequent sequence
rearrangements. Tn21 is inserted at the same site within Tn9 in
pAKU_1 and pHCM1; pHCM1 also harbors a second, diver-
gent copy of Tn21 elsewhere on the plasmid. The resistance
gene cassettes associated with the class I integrons (Fig. 2c)
differ in the two plasmids: sul1 and dfrA7 in pAKU_1 (encod-
ing sulfonamide and trimethoprim resistance respectively) and
dfrA14 in pHCM1.
An identical 9-kb sequence, incorporating blaTEM-1 (beta-
lactam resistance), sul2 (sulfonamide resistance), and strAB
(streptomycin resistance) genes flanked by IS26 elements (Fig.
2d), is present on both pAKU_1 and pHCM1. BLAST search-
ing (EMBL, November 2006) revealed that this is a promiscu-
ous sequence, referred to hereafter as bla/sul/str, that is also
present in the 120-kb IncF plasmid pRSB107 (unknown host,
Germany, 2005; EMBL accession no. AJ851089) (39) and the
F-like plasmid pU302L of serovar Typhimurium strain G8430
(CDC, Atlanta, GA; EMBL accession no. AY333434) (5). The
sequence has also previously been described in the genome of
serovar Typhimurium strain DT193 (Ireland, 1998; EMBL ac-
cession no. AY524415) and (in part) in an IncI plasmid of S.
enterica serovar Enteritidis (Italy, 1997; EMBL accession no.
AJ628353) (7). As Chen et al. suggest (5), it is likely that this
bla/sul/str sequence has moved as a single unit among enteric
bacteria. The flanking IS26 elements are members of the IS6
family, for which a transposition mechanism has been demon-
strated via two elements in direct orientation (21). Recombi-
nation via such elements is also a possibility. However in
pAKU_1, after accounting for inversions between IS26 ele-
ments (Fig. 3), we identified 6-bp direct repeats which were
likely target site duplications created upon insertion of the
outermost IS26 elements (to construct the composite se-
quence) and upon transposition of the whole unit into Tn21.
These direct repeats are shown as black, pink, and yellow filled
arrowheads in Fig. 2 and 3 and appear in the annotation. These
are also present (although similarly rearranged) in pHCM1
and pRSB107; thus, the insertion sites of bla/sul/str into
Tn21 are identical in these three plasmids.
FIG. 2. Transposons identified in pAKU_1. The gene order shown here agrees with the consensus from other sequences; note that Tn9 and
Tn21 have been disrupted by rearrangements in pAKU_1 and pHCM1 (Fig. 3a and d). The bla/sul/str sequence (d) appears to have been inverted
in between the flanking IS26 elements in pAKU_1 and pHCM1. Upper and lower bands represent forward and reverse strands, open arrowheads
represent inverted repeats, and filled arrowheads represent direct repeats (target site duplications). The insertion sites shown for panel d into panel
c, panel c into panel b, and panel b into panel a are conserved in pAKU_1, pHCM1, and pRSB107.
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A composite resistance transposon. Although the trans-
posons of pAKU_1 and pHCM1 have been disrupted by sev-
eral insertion elements and sequence rearrangements, se-
quence identity at the boundaries of Tn21 and the bla/sul/str
insertions suggests that Tn9, Tn21, and bla/sul/str may have
been acquired consecutively in one location and subsequently
transferred as a single unit between plasmids. Specifically, it is
hypothesized that some plasmid X first acquired Tn9, followed
by the transposition of Tn21 into Tn9, 3 of the cat gene (Fig.
2a and b). At some point bla/sul/str was inserted into the inte-
gron in Tn21, adjacent to tniA (Fig. 2c and d); this may have
occurred before or after the acquisition of Tn21 by plasmid X.
Subsequently, the resulting 24-kb composite transposon was
transferred into other plasmids. The transposition mechanism
is presumably mediated by the IS1 ends of Tn9, as direct
repeats are evident at opposite ends of the IS1 elements in
pAKU_1. The same composite transposon is evident in plas-
mid pRSB107, sequenced from an unknown bacterial host
from a wastewater treatment plant, albeit with additional re-
sistance gene insertions (Fig. 3c).
Once inserted into the ancestors of pAKU_1 and pHCM1,
the composite transposon sequence was disrupted by rear-
rangements mediated by insertion elements (Fig. 3). In
pAKU_1 two IS26 insertions mediated two inversions in the 5
end of the composite transposon (Fig. 3a); this is supported by
analysis of the configuration of IS26 target site duplications,
which were inverted along with the rest of the sequence be-
tween IS26 elements. One large inversion is responsible for
separating the 5 ends of Tn9 (IS1 and cat) and Tn21 (the tnpA
and tnpR 3 fragment) from the rest of the composite trans-
poson in pAKU_1 (Fig. 3a). This presumably has deactivated
the composite transposon in this plasmid, as the IS1 genes are
now in opposite orientation and separated by 62 kb, thus dis-
rupting Tn9. Tn21 is similarly disrupted, although bla/sul/str is
presumably still capable of transposition. In pHCM1, recom-
bination between an IS26 element inserted between tnpA and
tnpR and the 5 IS26 element of bla/sul/str resulted in deletion
of tnpR, tnpM, intI1, and the integron gene cassette (Fig. 3d).
IS4321 elements were also inserted within the Tn21 inverted
flanking repeats, demonstrated to be a preferred target site for
this IS element (30). In pRSB107, there are two additional
resistance gene insertions within the composite transposon
(Fig. 3c). The Tn4352B kanamycin/neomycin resistance trans-
poson is inserted at the 3 end of bla/sul/str. This transposon
comprises the aph gene flanked by IS26 elements and so may
have been inserted at this position via recombination with the
5 end IS26 element of bla/sul/str. A macrolide resistance
module is also inserted between the integron gene cassette
and bla/sul/str.
Comparison of pAKU_1 to serovar Typhi IncHI1 resistance
plasmids. The serovar Paratyphi A plasmid pAKU_1 was com-
pared to two IncHI1 plasmids isolated from serovar Typhi
strains during outbreaks in Vietnam in 1996. PCR primers
(Table 1) were designed based on the pAKU_1 sequence to
detect (i) unique features of the pAKU_1 IncHI1 backbone
compared to the serovar Typhi plasmid pHCM1 (Fig. 1a, A to
FIG. 3. The inferred ancestral version of the composite transposon (b) and its rearrangements in three plasmids. *, genes inserted relative to
the composite transposon; ∧, genes in the variable integron gene cassette. Colors and genes are the same as described in the legend of Fig. 2; pale
green indicates variable sequences at equivalent loci. Upper and lower bands represent forward and reverse strands, open arrowheads represent
inverted repeats, and filled arrowheads represent direct repeats. Regions of identical sequences are joined by colored boxes (tan when in direct
orientation and green when inverted). Black lines indicate PCR amplicons (E to J); labels correspond to those in Table 2 and Fig. 1.
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D), (ii) transposon boundaries within the composite transpo-
son (Fig. 1a and 3, G to I), and (iii) the insertion site of the
composite transposon into the IncHI1 backbone (Fig. 1a and 3,
J). Results from PCR assays designed to detect genes in the
intI1 variable gene cassette were previously reported by Wain
et al. (43) (Fig. 3, E and F). The regions amplified by PCR in
pAKU_1 and pHCM1 are indicated in Fig. 1 and 3; results of
the PCR assays are given in Table 2.
DISCUSSION
pAKU_1 is the first MDR plasmid from serovar Paratyphi A
to be sequenced and analyzed in detail. Like IncHI1 plasmids
isolated from MDR serovar Typhi, the DNA sequence is com-
posed of an IncHI1 backbone with numerous insertions of
mobile elements encoding resistance to chloramphenicol,
streptomycin, beta-lactams, trimethoprim, sulfonamides, and
tetracycline. Analysis of 81 serovar Paratyphi A isolates from
Pakistan confirmed that IncHI1 plasmids of similar size to
pAKU_1 are responsible for MDR in the majority of clinical
isolates analyzed from this area. Plasmids of similar size have
also been associated with MDR serovar Typhi in other regions
(14, 45). The pAKU_1 plasmid shares its IncHI1 backbone
with two plasmids that have been sequenced previously: pR27
from serovar Typhimurium and pHCM1 from serovar Typhi.
This shared backbone was inherited vertically from a common
ancestral plasmid and was therefore analyzed separately from
the mobile elements contained in the plasmid sequences,
which can theoretically be readily transferred horizontally into
distinct DNA backbones. Comparative analysis of the three
IncHI1 backbone sequences revealed that pAKU_1 is more
closely related to pR27 than to pHCM1, at the level of single-
nucleotide changes as well as larger insertions, deletions, and
rearrangements (Fig. 1b).
Plasmids pAKU_1 and pHCM1 share very similar resistance
gene complements, while pR27 has only one resistance gene
element (Tn10). It was hypothesized that the accumulation of
resistance since the 1960s when pR27 was first isolated is the
result of independent acquisition of resistance genes by two
distinct IncHI1 plasmid lineages. Plasmids pAKU_1 and pR27
share a related backbone, but pHCM1 and pAKU_1 have
acquired most of the same mobile elements. All three plasmids
encode the tetracycline resistance transposon Tn10; however,
the insertion site is at different positions in the IncHI1 back-
bone (Fig. 1a), suggesting that it, too, has been independently
acquired by each of the plasmids since their divergence.
The high degree of similarity in the resistance gene comple-
ment of pAKU_1 and pHCM1 is due to the independent
acquisition of a single composite transposon by both plasmids
(Fig. 2 and 3), which has since been subject to different rear-
rangements in each (Fig. 3). The proposed composite transpo-
son includes Tn9, Tn21, and a stretch of sequence including
the blaTEM-1, sul2, and strAB resistance genes that may itself be
mobile (Fig. 2d). The insertion sites of the composite transpo-
son are different in pAKU_1 and pHCM1, supporting the
hypothesis that the plasmids acquired their similar resistance
genes independently by horizontal transfer rather than by ver-
tical inheritance from a common ancestral plasmid. A BLAST
search of the proposed composite transposon sequence (Fig.
3b) against the EMBL database revealed its presence, without
rearrangements, in a plasmid from an unknown source,
pRSB107 (Fig. 3c). This plasmid has a distinct IncF backbone;
thus, the composite transposon appears capable of insertion
into a variety of genetic contexts. The strongest evidence for
the transfer of the composite transposon as a single unit is the
100% sequence identity in pAKU_1, pHCM1, and pRSB107
across the boundaries of insertion of (i) Tn21 into Tn9 and (ii)
bla/sul/str into Tn21. If Tn9, Tn21, and bla/sul/str were acquired
independently in each plasmid, it is highly unlikely that the
insertion sites of Tn21 and bla/sul/str and the resulting target
site duplication for bla/sul/str would be identical at the nucle-
otide level as they are in these three sequences. Thus, the most
likely explanation is that the insertions occurred once to form
a composite transposon, which was then able to move between
distinct plasmid backbones as a single unit using the IS1 ends
of Tn9.
There are currently no other resistance plasmid sequences
from serovar Typhi or serovar Paratyphi A available for com-
parative analysis. However, two IncHI1 serovar Typhi plas-
mids, isolated in 1996 from the same location in Vietnam as
pHCM1, were available for genetic analysis. PCR assays found
that both of these plasmids, pSTY6 and pSTY7 isolated in
1996, matched the backbone of pAKU_1 rather than pHCM1,
contained resistance genes present in pAKU_1 and not
pHCM1, and contained the composite transposon inserted at
the same site as in pAKU_1 (Table 2). It is highly unlikely that
the composite transposon has been inserted independently in
exactly the same position in both pAKU_1 and the serovar
Typhi plasmids. The more probable explanation is that the
serovar Typhi plasmids pSTY6 and pSTY7 and the serovar
Paratyphi A plasmid pAKU_1 share a recent common ancestor
from which they have each inherited the backbone and com-
TABLE 2. PCR assays in pAKU_1, pHCM1, pR27, and two
serovar Typhi plasmids from Vietnam
PCR region and
amplicona
PCR product in the indicated plasmidb
pR27 pHCM1 pSTY6 pSTY7 pAKU_1
Backbone
A X 0 X X X
B X 0 X X X
C X 0 X X X
D   X X X
Integron cassette
E   ND X X
F   X X X
Composite transposon
G  X X X X
H  0 X X X
I  0 X X X
J    X X
a PCR amplicons A and B target deletions in the pR27 and pAKU_1 backbone
compared to pHCM1, C targets an insertion in the pHCM1 backbone, and D
targets an insertion in the pAKU_1 backbone. Their positions are shown in Fig.
1. PCR amplicons E and F are PCR results for the detection of dfrA7 and sul1,
reported in Wain et al. (43), which are present in the variable integron gene
cassette (Fig. 2c) in pAKU_1 but not in pHCM1; G targets one end of the
insertion of bla/sul/str into Tn21; H and I target the boundaries of the insertion
of Tn21 into Tn9, and J targets the insertion site of Tn9 into the IncHI1
backbone.
b X, amplification of product the same size as for pAKU_1; 0, amplified
product of different size; , no amplification; ND, not determined.
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posite transposon insertion in a vertical fashion. This is sup-
ported by the matching results for PCR targeting the IncHI1
backbone (Table 2, A to D).
The observation that very closely related plasmids that share
a backbone carrying identical resistance insertions are present
in serovar Typhi and serovar Paratyphi A strongly suggests that
transfer of a plasmid between these two serovars has occurred.
However, it remains to be determined when this plasmid trans-
fer may have occurred and whether the direction of transfer
was from serovar Typhi to serovar Paratyphi A, or vice versa,
or via another bacterial host. Direct transfer between serovar
Typhi and serovar Paratyphi A may be possible, as incidents of
coinfection have been reported (15), as has chromosomal re-
combination between serovar Typhi and serovar Paratyphi A
(8). Whatever the direction of transfer, current data suggest
that plasmids similar to pAKU_1 have recently replaced the
pHCM1-type plasmids in some serovar Typhi populations.
This analysis clearly shows that plasmids found in serovar
Typhi and serovar Paratyphi A have independently acquired a
single composite transposon encoding MDR. This provides a
mechanism for the acquisition of a large number of drug re-
sistance genes in a single transfer and should serve as a warn-
ing that MDR can be acquired rapidly by human pathogens in
a single step. It also suggests that selection for resistance to one
antibiotic may lead to the proliferation of resistance to many.
Moreover, if MDR can be transferred rapidly from one serovar
to the other, whether by horizontal gene acquisition or plasmid
transfer, then the impact of selection for resistance in one
serovar can affect resistance in the other. This is an important
consideration in a clinical environment as it suggests that treat-
ment choices for serovar Typhi can impact treatment options
for serovar Paratyphi A infection and vice versa.
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ADDENDUM IN PROOF
Since acceptance of the manuscript, it has been suggested to
us that the following should be clarified. The transposon
Tn2670 (reviewed in reference 20) contains Tn21 inserted at
the same site in Tn9, but no bla/sul/str element, and is therefore
a possible progenitor for the composite transposon inferred
here.
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